In a groundbreaking move, the United States Food and Drug Administration has recently given its nod to two pioneering cell-based gene therapies, Casgevy and
Gene therapy’s trajectory is swiftly transforming, fueled by the pursuit of gene delivery mechanisms that are more efficient and less harmful. Historically, these methods
Mitchell Lee, CEO of Ora Biomedical, is on a mission to rapidly advance longevity research using high-throughput drug screening in C. elegans worms. With